‘Chemo brain’ may have targetable causes

BOSTON – The risk for cognitive decline following cancer treatment varies by both cancer and therapy types, and can range from subtle changes to severe deficits, according to a researcher. Patients...

Field of Interest: Oncology
Type: News Item

VIDEO: Don’t brush off subjective memory decline

COPENHAGEN – Researchers are paying more attention to subjective cognitive decline – a patient’s perceived notion of memory loss – even if the patients complete various cognitive tests with flying...

Field of Interest: Geriatrics
Type: News Item

Cerebral microbleeds’ depth may reveal dementia type

COPENHAGEN – The location of cerebral microbleeds appears to be strongly associated with dementia subtypes, perhaps reflecting the disorders’ underlying pathologies. "This regional association...

Field of Interest: Geriatrics
Type: News Item

Statin use linked to memory decline in elderly

CHICAGO – More liberal lipid targets in elderly patients and lower statin doses might offset the risk of memory decline associated with statin use in these patients, <link...

Field of Interest: Geriatrics
Type: News Item

Geriatric depression, pain respond to various drugs

ORLANDO – Duloxetine for the treatment of late-life depression missed its primary end point in a recent large randomized trial, but it did result in consistently significant clinical improvement,...

Field of Interest: Geriatrics
Type: News Item

Harness the ‘placebo’ in late-life depression

ORLANDO – The bad news about antidepressant therapy for patients whose first episode of depression occurs in late life is that the randomized trials show it’s no better than placebo. The good news is...

Field of Interest: Geriatrics
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.